Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation

Vancomycin exposure in the pre-engraftment period was associated with an increased risk for CMV reactivation after allogeneic HCT. Some gram-positive bacteria may protect against CMV reactivation.

Guardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Autores principales: Zhang, Shijia, Shanley, Ryan, Weisdorf, Daniel J., Rashidi, Armin
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2020
Materias:
Stimulus Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7322945/
https://ncbi.nlm.nih.gov/pubmed/32556279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001984
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares